CoBioTech ERA-NET

ERA-NET Cofund in Biotechnology

Innovation for Europe – Life sciences meet the market economy

The ERA-Net Cofund in Biotechnology – CoBioTech – is a Horizon 2020 ERA-Net Cofund that builds on and capitalizes on the success of its three predecessor ERANETs, ERA-IB2 (ERA-NET in Industrial Biotechnology 2), ERASysAPP (ERA-NET in Applied Biological Systems), and ERASynBio (ERA-NET in Synthetic Biology).

Cobiotech brings together 24 financing agencies with the following mission:

• Maximize synergies between member states' financing mechanisms;
• Promote the cross-border circulation of knowledge;
• Promote the benefits of the bioeconomy to society;
• Maintain and strengthen the leading position of biotechnology in Europe;

CoBioTech intends to form a Biotechnology Hub, an entirely new concept that aims to bring together stakeholders from different areas of biotechnology, with the goal of aligning different national/regional instruments and strategies with the objectives of the Horizon 2020 Key Enabling Technologies (KET) program, and also to raise public awareness of the benefits of the industrial use of biotechnology.

CoBioTech intends to implement additional funding activities (including the launch of other joint Calls without EU co-financing), which promise to contribute to the development of R&D in Industrial Biotechnology in line with the strategic agenda and objectives defined in the "Hub," also providing a platform to support stakeholders in terms of communication, information sharing, networking, and financing.

FCT participates in CoBioTech but does not participate in Call first Call , launched in December 2016.